# Ondansetron for Postspinal Anesthesia Hypotension

> **NCT05475873** · NA · COMPLETED · sponsor: **General Hospital of Ningxia Medical University** · enrollment: 120 (actual)

## Conditions studied

- Adverse Effect

## Interventions

- **DRUG:** normal saline
- **DRUG:** Ondansetron 4 mg
- **DRUG:** Ondansetron 8 mg

## Key facts

- **NCT ID:** NCT05475873
- **Lead sponsor:** General Hospital of Ningxia Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-18
- **Primary completion:** 2023-10-27
- **Final completion:** 2023-10-27
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05475873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05475873, "Ondansetron for Postspinal Anesthesia Hypotension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05475873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*